Skip to content

Use of Amniontic Membrane as biological dressing for the treatment of bed sores in comparison with conventional dressings.

Use of Amniotic Membrane as biological dressing for the management of pressure ulcers in comparison with conventional saline dressings.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/11/002167
Enrollment
30
Registered
2011-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients in prolonged immobilization as a result of illness/old age/ neurological or musculoskeletal condition

Interventions

Intervention1: Amniotic membrane as a Biological dressing: Intervention is use of Amniotic membrane as a biological dressing. After obtaining informed consent from the patient, the labour room will be

Sponsors

Fluid Research Grant from the Institutional Review Board Christian Medical College Vellore
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Grade 2 pressure ulcers as per the NPUAP guidelines. 2) Pressure ulcers in the following group of patients with: - Spinal cord injury - Traumatic brain injury - Stroke - Geriatric patients bed bound and with ulcers due to various co-morbidities (eg: severe degenerative joint disease, old CVA, dementia etc.)

Exclusion criteria

Exclusion criteria: 1)Infected or with necrotic tissue 2) Anemia (Hb 3) Hypoalbuminemia (albumin 4) patients with traumatic brain injury sequelae who are restless and agitated.

Design outcomes

Primary

MeasureTime frame
Reduction in the PUSH scores and decrease in the area of the pressure ulcer as measured and calculated by the image software.Timepoint: Reduction in the PUSH scores and decrease in the area of the pressure ulcer as measured and calculated by the image software. Time taken from start of intervention/conventional dressing to end is 21 days(3 weeks).

Secondary

MeasureTime frame
improvement in serum albumin levels.Timepoint: 3 weeks

Countries

India

Contacts

Public ContactDr Bobeena Rachel Chandy

Christian Medical College, Vellore, Tamil Nadu

bobeenachandy@cmcvellore.ac.in09894762055

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026